Nasdaq

Purple Biotech Discovers Potential of NT219 and 5-FU Combination Therapy in Inhibiting Brain Metastasis of Colorectal Cancer

Purple Biotech Ltd. announced a significant study revealing that their drug NT219, combined with 5-fluorouracil (5-FU), effectively inhibits colorectal cancer brain metastasis by targeting the IRS2 ...
Healio

’Reassuring’ findings show eliminating 5-FU bolus in GI cancer does not affect survival

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Administration of 5-FU bolus did not affect survival for ...
EurekAlert!

5-FU chemotherapy linked to rare brain toxicity in cancer patient

“The patient’s symptoms resolved after permanently stopping 5-FU and administering lactulose and intravenous fluids, therefore supporting the diagnosis of hyperammonemic encephalopathy due to 5-FU.” ...
ascopubs.org

Multicenter Phase II Study of Bimonthly High-Dose Leucovorin, Fluorouracil Infusion, and Oxaliplatin for Metastatic Colorectal Cancer Resistant to the Same Leucovorin and ...

Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of ...
ascopubs.org

Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer

Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical ...